Legend Biotech Corporation (LEGN)

Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	286.75	1,278	786.03	688.94	455.69
Short-Term Investments	835.93	30.34	54.02	193.46	50
Trading Asset Securities	-	0.66	185.6	-	-
Cash & Short-Term Investments	1,123	1,309	1,026	882.4	505.69
Cash Growth	-14.21%	27.60%	16.23%	74.49%	218.20%
Accounts Receivable	6.86	101.43	0.28	50.5	75.62
Other Receivables	118.03	55.63	44.24	8.04	7
Receivables	124.89	157.06	44.52	58.55	82.62
Inventory	23.9	19.43	10.35	1.75	1.8
Prepaid Expenses	12.37	12.23	17.33	5.72	3.46
Other Current Assets	0.07	0.36	1.27	1.44	0.38
Total Current Assets	1,284	1,498	1,099	949.85	593.94
Property, Plant & Equipment	201.22	189.23	160.76	140.79	111.88
Long-Term Investments	4.36	4.36	-	4.71	-
Other Intangible Assets	2.16	4.06	3.41	4.68	2.85
Long-Term Accounts Receivable	-	-	0.4	-	-
Other Long-Term Assets	178.49	153.16	67.28	19.44	13.41
Total Assets	1,670	1,849	1,331	1,119	722.09
Accounts Payable	38.59	30.66	32.89	7.04	4.91
Accrued Expenses	62.91	60.68	152.73	104.38	74.36
Short-Term Debt	-	-	-	-	0.33
Current Portion of Leases	4.79	3.18	3.56	0.91	1.46
Current Income Taxes Payable	20.67	7.2	9.77	9.49	8.8
Current Unearned Revenue	47.41	53.08	0.45	0.3	0.28
Other Current Liabilities	103.27	61.63	98.38	107.08	25.42
Total Current Liabilities	277.65	216.42	297.79	229.2	115.57
Long-Term Debt	301.2	281.33	260.93	120.46	-
Long-Term Leases	44.61	44.17	20.04	1.59	1.91
Long-Term Unearned Revenue	6.15	55.27	7.66	1.87	2.05
Long-Term Deferred Tax Liabilities	-	-	-	-	4.24
Other Long-Term Liabilities	-	0.06	0.23	0.4	0.55
Total Liabilities	629.61	597.24	586.65	353.52	124.32
Common Stock	0.04	0.04	0.03	0.03	0.03
Additional Paid-In Capital	2,696	2,637	1,657	1,261	708.31
Retained Earnings	-1,662	-1,485	-966.46	-520.11	-116.53
Comprehensive Income & Other	6.27	98.93	53.72	24.57	5.96
Shareholders' Equity	1,041	1,251	744.31	765.94	597.77
Total Liabilities & Equity	1,670	1,849	1,331	1,119	722.09
Total Debt	350.6	328.67	284.53	122.97	3.7
Net Cash (Debt)	772.08	980.05	741.12	759.43	501.99
Net Cash Growth	-21.22%	32.24%	-2.41%	51.28%	228.45%
Net Cash Per Share	4.22	5.57	4.66	5.39	4.25
Filing Date Shares Outstanding	183.65	181.91	165.07	154.23	133.01
Total Common Shares Outstanding	183.65	181.91	165.07	154.23	133.01
Working Capital	1,006	1,281	801.33	720.65	478.38
Book Value Per Share	5.67	6.88	4.51	4.97	4.49
Tangible Book Value	1,038	1,247	740.9	761.26	594.92
Tangible Book Value Per Share	5.65	6.86	4.49	4.94	4.47
Land	2.89	2.89	2.89	2.89	2.89
Buildings	65.54	65.54	45.08	16.01	11.21
Machinery	44.92	45.48	46.26	38.27	29.17
Construction In Progress	4.4	3.04	14.18	41.37	27.81
Leasehold Improvements	21.28	23.12	21.97	20.91	11.89

Source: S&P Capital IQ. Standard template. Financial Sources.